1)藤田淳也,島野高志,福島幸男,他:小腸GISTの診断と治療.外科 63:1062-1069,2001
2)Miettinen M, Lasota J:Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Wirchows Arch 438:1-12, 2001
3)Nishida T, Hirota S:Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopthol 15:1293-1301, 2000
4)Hirota S, Isozaki K, Moriyama Y et al:Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580, 1998
5)Levitzki A:Protein tyrosine kinase inhibitors as novel therapeutic agents.:Pharmacol Ther 82:231-239, 1999
6)Joensuu H, Roberts PJ, Sarlomo-Rikala M et al:Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 344:1052-1056, 2001
7)西田俊朗:Gastrointestinal stromal tumor(GIST).跡見 裕,他(監修);消化器外科学レビュー2007.総合医学社,2007,pp182-187
8)Crosby JA, Catton CN, Davis A et al:Malignant gastrointestinal stromal tumors of the small intestine:a review of 50 cases from a prospective database. Ann Surg Oncol 8:50-59, 2001
9)Miettinen M, Makhlouf H, Sobin LH, et al:Gastroinetestinal stromal tumors of the jejunum and ileum;a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Patol 30:477-489, 2006
10)Jager PL, Gietema JA, van der Graaf WT:Imatinib mesylate for the treatment of gastrointestinal stromal tumors:best monitored with FDG PET. Nucl Med Commun 25:434-438, 2004
11)Kubota T:Gastrointestinal stromal tumor(GIST)and imatinib. Int J Clin Oncol 11:184-18 2006
12)Kamiyama Y, Aihara R, Nakabayashi T et al:18F-fluorodeoxyglucose positron emission tomography:useful technique for predicting malignant potential of gastrointestinal stromal tumors.:World J Surg 29:1429-1435, 2005
13)大野 玲,小畑 満,菊池章文,他:FDG-PETにより発見された横行結腸GISTの1例.日臨外会誌 67:2419-2423,2006
14)藤井博史,井出 満,安田聖栄,他:新しい画像検査・診断法と今後の展開-FDG-PETによる消化管腫瘍の診断.胃と腸 39:1625-1633,2004